Sinopharm
1099.HK
#2700
Rank
โ‚น643.40 B
Marketcap
โ‚น206.18
Share price
-0.41%
Change (1 day)
-2.41%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.827 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.827 Trillion. In 2025 the company made a revenue of โ‚น7.827 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.625 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.827 T2.65%
2024โ‚น7.625 T-5.1%
2023โ‚น8.035 T5.42%
2022โ‚น7.622 T-2.1%
2021โ‚น7.785 T16.85%
2020โ‚น6.662 T14.95%
2019โ‚น5.796 T21.52%
2018โ‚น4.769 T5.93%
2017โ‚น4.502 T27.22%
2016โ‚น3.539 T5.37%
2015โ‚น3.358 T9.14%
2014โ‚น3.077 T17.22%
2013โ‚น2.625 T25.94%
2012โ‚น2.084 T34.61%
2011โ‚น1.548 T55.34%
2010โ‚น996.87 B35.79%
2009โ‚น734.14 B37.56%
2008โ‚น533.70 B31.43%
2007โ‚น406.08 B40.26%
2006โ‚น289.51 B